2,343 Followers on Owler

bluebird bio

is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of genetic diseases... Read more
OverviewCompetitorsAcquisitionsFundingNews & Insights

bluebird bio

is a Massachusetts-based biotechnology company that researches and develops gene therapies for the treatment of genetic diseases... Read more
bluebird bio CEO: Andrew Obenshain

CEO

Andrew Obenshain

CEO Approval Rating

73/100

1992

PublicAcquisition Pending from The Carlyle GroupNASDAQBLUE

Pharmaceuticals & Biotechnology
Biotechnology
2836 NAICS listing

Annual Revenue
$83.8M
Employees
520
Funding
$821.4M
Acquisitions
1

News

Acquisition
Feb 21, 2025
Business Wire
bluebird bio Was acquired by The Carlyle Group for undisclosed amounted
Partnership
Dec 04, 2024
Beckers Hospital Review
CMS partners with 2 companies on sickle cell therapies

bluebird bio Competitors

1Sangamo
2Intellia
3CRISPR
4Emmaus
5Elcelyx Therapeutics
6Gelesis
7Asklepios
8Dimension Therapeutics
9Lysogene
10Merck
See 15+ competitors

Trending Companies